Abstract | INTRODUCTION: CASE REPORT: We report a medium aged patient who developed secondary hemiparesis after 18 months of medical treatment. MRI revealed pons herniation into the clivus. There was improvement with conservative treatment. Secuencial MRIs are presented showing the tumor at the moment of the diagnosis, tumor shrinkage and pons herniation. DISCUSSION: Some studies have shown that a significant and rapid tumor shrinkage resulting from treatment with cabergoline can occur and it is thought that some complications are related with this tumor regression, as in the presented case.
|
Authors | Jesús Moles Herbera, David Rivero Celada, Inmaculada Montejo Gañan, David Fustero de Miguel, Carlos Fuentes Uliaque, Ana Carmen Vela Marín |
Journal | Pituitary
(Pituitary)
Vol. 18
Issue 1
Pg. 68-71
(Feb 2015)
ISSN: 1573-7403 [Electronic] United States |
PMID | 24522845
(Publication Type: Journal Article)
|
Chemical References |
- Antineoplastic Agents
- Ergolines
- Cabergoline
|
Topics |
- Antineoplastic Agents
(therapeutic use)
- Cabergoline
- Ergolines
(therapeutic use)
- Humans
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Pituitary Neoplasms
(drug therapy, pathology)
- Pons
(pathology)
- Prolactinoma
(drug therapy, pathology)
|